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ID4 Intraduodenal glucose infusion at 4 kcal/min





East Asians appear to secrete less insulin than Caucasians
following oral glucose suggesting that impaired insulin
secretion is fundamental to the pathogenesis of type 2
diabetes [1]. Information about the secretion of the incretin
hormones, GIP and GLP-1, dependent on duodenal glucose
load [2], in East Asians is limited [3]. We have evaluated
glycemic, insulinemic and incretin hormone responses to
intraduodenal glucose in healthy Han Chinese.
We studied eleven Han Chinese (HC) and eight Cau-
casian (C) healthy men; the latter included in a previous
study [2]. Each subject attended following an overnight
fast. A catheter, incorporating an infusion channel opening
12 cm beyond the pylorus, was inserted intranasally [2].
An IV cannula was placed in an antecubital vein. Intra-
duodenal (ID) glucose (25 g/100 mL) was infused at
4 kcal/min from t = 0 to 120 min. Blood was collected at
t = 0, 15, 30, 45, 60, 90, 105 and 120 min for measure-
ments of blood glucose, plasma insulin, GIP and GLP-1.
Insulin secretion was estimated as the change in insulin
divided by the change in glucose at 30 min (DI0–30/
DG0–30). Insulin sensitivity was estimated as 1/fasting
insulin. The disposition index (DIO) was calculated as
DI0–30/DG0–30X 1/fasting insulin. Unpaired Student’s t test
was used in analysis.
Han Chinese younger than Caucasians (24.8 ± 1.3 HC
vs. 45.3 ± 3.8 C years, P\ 0.01); there was no difference
in BMI (25.1 ± 1.7 HC vs. 28.3 ± 0.7 C kg/m2). There
were no differences in fasting glucose (5.4 ± 0.1 HC vs.
5.7 ± 0.2 C, mmol/L, P = 0.10) or glycemic response to
ID glucose. Fasting (4.9 ± 0.8 HC vs. 19.2 ± 3.9 C, mU/L,
P\ 0.01) and AUC0–120 (13,234 ± 2,134 HC vs.
43,133 ± 12,197 C, mU/L min, P = 0.01) insulin and
insulin secretion (15.5 ± 5.2 HC vs. 63.2 ± 22 C,
P = 0.02) were lower in Han Chinese. The DIO was not
different (2.9 ± 0.4 HC vs. 3.5 ± 1.3 C, P = 0.63). Fasting
(16.2 ± 1.3 HC vs. 22 ± 2.9 C, pmol/L, P = 0.06) and
AUC0–120 (5,836 ± 337 HC vs. 7,975 ± 739 C, pmol/
L min, P = 0.01) GIP were lower in Han Chinese. There
was no difference in fasting (25 ± 3.3 HC vs. 19.8 ± 2.4 C,
pmol/L, P = 0.24) or glucose-stimulated GLP-1 (Fig. 1).
Our study indicates that, in response to intraduodenal
glucose infusion, insulin secretion is less and insulin sen-
sitivity is greater in Han Chinese than in Caucasians,
associated with reduced GIP, but comparable GLP-1,
secretion and DIO—the latter reflecting increased insulin
sensitivity in Han Chinese. Few studies have evaluated GIP
and GLP-1 responses within East Asian populations. In the
only direct comparison [3], healthy Japanese were reported
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to have higher GIP and lower GLP-1 than Caucasians, but
methodological limitations preclude meaningful interpre-
tation. The reduced GIP response we observed could con-
tribute to the diminished insulin response. In type 2
diabetes, the insulinotropic capacity of GIP is markedly
reduced, and the reduction in GIP is likely to be of primary
relevance to ‘health.’
Limitations of our study are that the cohort was of small
size and exclusively male, that responses to intraduodenal,
rather than oral, glucose were evaluated and that there was a
difference in age between the groups, although GIP (and
GLP-1) response is apparently unaffected by age [4]. Mean
BMI was higher in the Caucasians, albeit non-significantly,
which may represent a confounder, although it appears that
body weight does not affect the GIP response to nutrients [5].
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Fig. 1 Blood glucose (a),
plasma insulin (b), GIP (c) and
GLP-1 (d) concentrations at
baseline and in response to a
120-min intraduodenal glucose
infusion at 4 kcal/min in Han
Chinese (Filled circles with
bold line) and Caucasian (Empty
circles with dotted line)
subjects. Data are mean ± SEM
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